Improvement of intestinal function in cystic fibrosis patients using probiotics;Optimización de la función intestinal en pacientes con fibrosis quística mediante la administración de probióticos

Anales de Pediatria

Volumn 69, Issue 6, 2008, Pages 501-505

  Infante Pina, D ^a   Redecillas Ferreiro, S ^a   Torrent Vernetta, A ^a   Segarra Canton O ^a   Maldonado Smith, M ^a   Gartner Tizziano, L ^b   Hidalgo Albert, E ^c  

^a Unidad de Gastroenterología Hepatología y Soporte Nutricional   (Spain)

^b Unidad de Neumología Unidad de Fibrosis Quística España   (Spain)

^c HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Bacterial overgrowth; Cystic fibrosis; Improved intestinal function; Probiotics

Indexed keywords

NITROGEN; PROBIOTIC AGENT; SUGAR;

ADOLESCENT; ARTICLE; BACTERIAL OVERGROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FECES ANALYSIS; HUMAN; HYDROGEN BREATH TEST; INTESTINE FUNCTION; LACTOBACILLUS RHAMNOSUS; NEAR INFRARED SPECTROSCOPY; PRESCHOOL CHILD; STEATORRHEA; TREATMENT DURATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HUMANS; INTESTINES; PILOT PROJECTS; PROBIOTICS;

EID: 59949092698     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/S1695-4033(08)75231-7     Document Type: Article

References (30)

1. Smyth R.L., Croft N.M., O'Hea U., Marshall T.G., and Ferguson A. Intestinal inflammation in cystic fibrosis. Arch Dis Child 82 (2000) 394-399
2. Raia V., Maiuri L., De Ritis G., De Vizia B., Vacca L., Conte R., et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 47 (2000) 344-350
3. Lloyd-Still J.D., Uhing M.R., Arango V., Fusaro A., and Kimura R.E. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat. J Pediatr Gastroenterol Nutr 26 (1998) 489-495
4. Van Elburg R.M., Uil J.J., Van Aaderen W.M., Mulder C.J., and Heymans H.S. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediatr Res 39 (1996) 985-991
5. White H., Wolfe S.P., Foy J., Morton A., Conway S.P., and Brownleek B. Nutritional intake and status in children with cystic fibrosis: does age matter?. J Pediatr Gastroenterol Nutr 44 (2007) 116-123
6. Hamilton J.D., Dyer N.H., Dawson A.M., O'Grady F.W., Vince A., Feuton J.C., et al. Assessment and significance of bacterial overgrowth in the small bowel. Q J Med 39 (1970) 265-285
7. Norkina O., Burnett T.G., and De Lisle R.C. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Inmunol 72 (2004) 6040-6049
8. Lewindon P.J., Robb T.A., Moore D.J., Davidson G.P., and Martin A.J. Bowel dysfuntion in cystic fibrosis: importance of breath testing. J Pediatr Child Health 34 (1998) 79-82
9. Fridge J.L., Conrad C., Gerson L., Castillo P.O., and Cox K. Risk factors for small bowell bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 44 (2007) 212-218
10. Resta-Lenert S., and Barrett K.E. Probiotics and commensals reverse TNF-alpha and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130 (2006) 731-746
11. Doron S., and Gorbach S.L. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 4 (2006) 261-275
12. Isolauri E., Grönlund M.M., Salminen S., and Arvilommi H. Why don't we bud?. J Pediatr Gastroenterol Nutr 30 (2000) 214-216
13. Vanderhoof J.A., and Young R.J. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 27 (1998) 323-332
14. Binkovitz L.A., Allen E., Bloom D., Long F., Hammond S., Buonomo C., et al. Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. AJR Am J Roentgenol 172 (1999) 517-521
15. Hamilton L.H. Breath tests in gastroenterology. 2nd ed. (1998), QuinTron Instrument Company, Milwaukee
16. Tormo R., and Infante D. Malabsorción de hidratos de carbono en la infancia. Aplicación de la prueba de hidrógeno espirado. Premio "Alexander Frías i Roig" sobre Nutrición Infantil; 1987 (1988), Sociedad Nestlé A.E.P.A., Barcelona P. 9-30
17. Kerlin P., and Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95 (1998) 982-988
18. Benini L., Caliari S., Guidi G.C., Vaona B., Talamini G., Vantini I., et al. Near infrared spectrometry for faecal fat measurement: comparison with conventional gravimetric and titrimetric methods. Gut 30 (1989) 1344-1347
19. Stein J, Purschian B, Bieniek U, Caspary WF, Lembcke B. Validation of near-infra-red reflectance analysis (NIRA) for the assessment of fecal fat, nitrogen and water. A new approach to malabsorption syndromes. San Francisco, California: Proceedings of the Annual Meeting of the American Gastroenterological Association (AGA), May 10-13, 1992.
20. Benini L., Caliari S., Bonfante F., Guidi G.C., Brentegani M.T., Castellani G., et al. Near infrared reflectance measurement of nitrogen faecal losses. Gut 33 (1992) 749-752
21. Perman J.A., and Modler S. Glycoproteins as substrates for production of hydrogen and methane by colonic bacterial flora. Gastroenterology 83 (1982) 388-393
22. Perman J.A., Modler S., Barr R.G., and Rosenthal P. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology 87 (1984) 1358-1363
23. Gregory P.C. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J Pediatr Gastroenterol Nutr 23 (1996) 513-523
24. Laubitz D., Zabielski R., Wolinski J., Nieminuszczy J., and Grzesiuk E. Physiological and chemical characteristics of antibacterial activity of pancreatic juice. J Physiol Pharmacol 54 (2003) 283-290
25. Rubinstein E., Mark Z., Haspel J., Ben-Ari G., Dreznik Z., Mirelman D., et al. Antibacterial activity of the pancreatic fluid. Gastroenterology 88 (1985) 927-932
26. O'Brien S., Mulcahy H., Fenlon H., O'Broin A., Casey M., Burke A., et al. Intestinal bile acid malabsortion in cystic fibrosis. Gut 34 (1993) 1137-1141
27. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 20 (2004) 813-819
28. Bruzzese E., Raia V., Spagnuolo M.I., Volpicelli M., De Marco G., Maiuri L., et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study. Clin Nutr 26 (2007) 322-328
29. Tormo R., Infante D., Roselló E., and Bartolomé R. Efecto de la ingesta de leche fermentada con Lactobacillus casei DN-114 001 sobre la flora intestinal. An Pediatr 65 (2006) 448-453
30. Grand R. War and peace at the intestinal epithelial surface: an integrated view of bacterial commensalism versus bacterial pathogenicity. J Pediatr Gastroenterol Nutr 46 Suppl 1 (2008) E6-E7